(833) 317-6278
Book a Demo
Henry Ford
Gray shield icon
Is this you?
Claim your profile.

Henry Ford

AS SEEN ON
thelincolnianonline.com, Frontiers, Red Journal, Nature Portfolio, American Journal of Ophthalmology

Preston's Summary

Henry Ford is a versatile journalist who writes for various publications, including Zolmax News, Detroit Free Press, Elephant Magazine, All About Circuits, and Red Journal. His articles cover a wide range of topics, including stock market analysis, technology, cooking, travel, and healthcare. With a diverse portfolio of work, Henry brings a unique perspective to his writing and provides valuable insights to his readers.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Detroit, Michigan, United States (Local)

Coverage Attributes:

Beta
Investment Analysis: 30 %
Cites Data: 29 %
Press Release: 11 %
How To Guide: 9 %
Private Sector Announcements: 5 %

Themes Covered:

Most Recent Topics:

  • Health and Wellness
  • Nutrition
  • Medical Research
  • Cooking
  • Technology
  • Business and Finance

Pitching Insights

Henry Ford's articles cover a variety of topics, including tech, finance, and business. The coverage also includes "How To Guide" and reviews. Given the mix of content, Henry would likely be interested in pitches that provide practical guidance or actionable insights related to stock market investments, ETFs, dividends as well as technology updates and business trends.

If you have expertise in providing clear instructions for financial strategies or technological advancements within the stock market context or if you can offer comprehensive reviews of investment products or technological tools relevant to finance and business sectors then your pitch is more likely to capture his attention.

While no specific geographic focus is indicated for Henry’s articles he covers international stocks which implies a global outlook on the financial markets.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
John W.

John W.

Eurasia Review
****w@***********org
Publications
Nature Portfolio, MDPI
Most recent topics
Scientific, Culture & Society, Sports, Entertainment News, Gaming
Anna Jones

Anna Jones

Journalist
Publications
The Echo, Medical Xpress, Tallahassee Democrat, Birmingham Times, The Post
Most recent topics
Health & Wellbeing, Healthcare & Pharmaceutical, Scientific, House & Home, Health
David J

David J

Financial Writer
Publications
BioRxiv, Medical Journal of Australia
Most recent topics
Sports, Scientific, Healthcare & Pharmaceutical, Government & Politics, Crime
Sarah M

Sarah M

Reporter
****h@*****a
Publications
Medical Economics
Most recent topics
Content & Publishing, Scientific, Deals & Promotions, Healthcare & Pharmaceutical, House & Home
Lee Ann

Lee Ann

Managing Editor, Neurology: Clinical Practice
***n@******m
Publications
MDPI, Silsbee Bee, Fair Observer, ThurstonTalk
Most recent topics
Personal Finance, Family & Relationships, Sports, Human Resources & Employment, Deals & Promotions
Ayanna Amadi

Ayanna Amadi

Publications
Medriva
Most recent topics
Healthcare & Pharmaceutical, Scientific, Health & Wellbeing, Tragedy, Government & Politics

Articles

The Lancet

Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

By: Julie A. Schmittdiel, Henry Ford, Bernard J. Tyson, Caryn Oshiro, Margaret Nolan, Luis A. Rodriguez, Holly Finertie, Lisa K. Gilliam, Andrew J. Karter, Bennett Gosiker, Sarah Dombrowski, W. Thomas, Andrea E. Cassidy-Bushrow, Romain S. Neugebauer

Summary Background Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) improve cardiorenal outcomes in patients with type 2 diabetes.

© 2024 Intelligent Relations